Intetumumab

Tax included
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer.
MedChemExpress 
HY-P99296

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-Kinase/protease
CAS
725735-28-4